Yellowstone Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$441K Sell
5,466
-509
-9% -$40.8K 0.25% 93
2017
Q3
$465K Buy
+5,975
New +$496K 0.24% 103
2016
Q3
$1.32M Buy
15,315
+3,058
+25% +$266K 0.49% 58
2016
Q2
$1.06M Buy
12,257
+94
+0.8% +$7.6K 0.46% 67
2016
Q1
$912K Buy
12,163
+324
+3% +$24.4K 0.39% 63
2015
Q4
$911K Buy
11,839
+42
+0.4% +$3.16K 0.41% 51
2015
Q3
$790K Buy
11,797
+962
+9% +$70.9K 0.37% 52
2015
Q2
$803K Buy
10,835
+524
+5% +$40K 0.36% 52
2015
Q1
$804K Buy
+10,311
New +$782K 0.41% 53
2014
Q3
Sell
-13,195
Closed -$841K 198
2014
Q2
$841K Sell
13,195
-234
-2% -$14.2K 0.49% 47
2014
Q1
$826K Sell
13,429
-236
-2% -$13.7K 0.52% 42
2013
Q4
$784K Buy
+13,665
New +$775K 0.51% 45

Other funds holding MDT

Yellowstone Partners's MDT Position: Q4 2017 in Review

Yellowstone Partners reduced its Medtronic (MDT) stake by 8.5% in Q4 2017, selling an estimated $40.8K and leaving 5,466 shares worth $441K. The position accounts for 0.25% of the portfolio, ranked #93.

Yellowstone Partners first reported a position in MDT in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.32M in Q3 2016. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Yellowstone Partners held 5,466 shares of Medtronic worth $441K as of Q4 2017.
  • Yellowstone Partners sold 509 Medtronic shares in Q4 2017, an estimated $40.8K.
  • Medtronic made up 0.25% of Yellowstone Partners's portfolio in Q4 2017, its #93 holding.
  • Yellowstone Partners first reported a position in Medtronic in Q4 2013 and has held it in 12 quarters since.
  • Yellowstone Partners's Medtronic position peaked at $1.32M in Q3 2016.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.